Reading Room Production — page 450

'ies re that I From: "Korch, George (HHS/ASPR/IO)" @hhs.gov> To: @who.eop.gov, @who.eop.gov, "Emanuel, Ezekiel (NIH/CC/BEP) [E]" @nih.hhs.gov>, "Ezekiel Emanuel" @omb.eop.gov>, "Lurie, Nicole (HHS/ASPR/IO)" @hhs.gov>, "Fauci, Anthony (NIH/NIAID) [E]" <Anthony.Fauci@nih.hhs.gov>, "Robinson, Robin (HHS/ASPR/BARDA)" @HHS.GOV>, "Merchant, Raina (HHS/ASPR)" @hhs.gov>, "Borio, Luciana L. (FDA)" @fda.hhs.gov> Cc: "Korch, George (HHS/ASPR/IO)" @hhs.gov> Subject: Synopsis of Conversation with Pharma/Bio Reps 29 Jan 2010 Date: Sat, 30 Jan 2010 13:57:49 -0500 Importance: Normal Attachments: Synopsis_of_Meeting_with_Pharma_and_Biotech_VP's_at_EEOB_on_29_Jan.doc Heidi, et al.: I have summarized the conversation with the VP's and representatives from the pharmaceutical / biotechnology industries regarding incentives promoting greater participation by industry in our public health emergency medical countermeasure enterprise. Where possible, I identify follow-on actions that derive directly from the conversation. There are still important conversations to continue with our commercial partners. Please feel free to modify or add information or perspectives that I did not adequately capture. Also, I did not quote by name the discussions offered by our industrial partners. Best regards George George W. Korch Jr. Senior Science Advisor Assistant Secretary for Preparedness and Response Department of Health & Human Services